Andrew Hillman, in full.

Andrew Jonathan Hillman is a biotech entrepreneur, healthcare investor, and strategic advisor based in Dallas, Texas. He is the principal of Hillman Ventures, a private family office founded in 1995, and his career spans three decades of building, operating, and exiting companies across FDA-regulated healthcare.

A Dallas family legacy of building

The drive to build is inherited. Andrew Hillman's grandfather, Henry B. Levine, founded Midway Auto Supply in Dallas, a business grown on service, relationships, and steady execution. Three generations on, Andrew Hillman leads Hillman Ventures from the same city, continuing a Dallas family legacy of building durable companies guided by a simple standard: efficiency, innovation, integrity.

Four pillars of impact

Andrew Hillman's career rests on four connected pillars, each built on the operating discipline of the last.

An operator first

Before he was an investor, Andrew Hillman was an operator. He co-founded and led companies across surgical hospitals, ambulatory surgical centers, clinical laboratories, pharmacy, and medical devices, with a documented record of more than 89 ventures and more than 85 strategic exits. That operating experience, in regulated, capital-intensive, and clinically demanding businesses, is the foundation for everything that followed.

From building companies to backing them

Today his focus is forward-looking. Through Hillman Ventures, he invests in frontier biotech and regenerative medicine for inflammation, damaged tissue, and tumor-based cancers, applying the capital discipline and regulatory judgment earned over three decades. He approaches investment the way an operator does, with attention to the science, the manufacturing, and the path to patients, not the pitch alone. His perspective on these questions is collected in his featured insights and on the venture platform.

Advisory and expertise

Andrew Hillman also advises founders, investors, and operators on FDA regulatory strategy, commercialization, and healthcare venture development through his advisory practice. In parallel, he serves as a healthcare compliance and operations expert witness, work documented on his dedicated expert witness profile. He is the author of white papers spanning regenerative medicine, the FDA Section 351(a) biologics pathway, and oncology, including work on Wharton's Jelly mesenchymal stem cell-derived exosomes and on Targeted Osmotic Lysis (TOL 2.0).

Giving and community

His philanthropy centers on education and community. It includes the Andrew Hillman Family Room at the Lamplighter School in Dallas, the Andrew Hillman Scholarship for Entrepreneurs, and the Andrew Hillman Grant for Biotech, alongside support for community and charitable organizations. The full account is maintained at his community and giving site.

A record you can verify

Andrew Hillman's background is documented in an independent, source-cited public record and in established identity registries. The complete account, including public filings, recognitions, and federal records, is maintained at the public record. His verified professional identity is linked below.